Click a link below to view the mailing archive as if it had been sent to you.
| 2020-02-29 12:15 | | The FDA OKs generic Daraprim, the Martin Shkreli therapy that triggered an unending tempest over drug pricing and more... |
| 2020-02-29 00:15 | | Bristol-Myers Squibb reaches tentative deal to end long-running Medicaid rebate lawsuit and more... |
| 2020-02-28 12:15 | | Gilead hungry for 'don't eat me' cancer biotech: reports and more... |
| 2020-02-28 00:15 | | Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut? and more... |
| 2020-02-27 12:15 | | Pharmacquired: Where are all the deals? and more... |
| 2020-02-27 00:15 | | Amarin aims for Vascepa boom with doubled sales force nearly in place and more... |
| 2020-02-26 12:15 | | Endo touts financial 'flexibility' as massive opioid settlements mount industrywide and more... |
| 2020-02-26 00:15 | | Federal judge rules clinical trial sponsors must publish a decade’s worth of missing data and more... |
| 2020-02-25 12:15 | | Mallinckrodt floats $1.6B opioid deal, bankruptcy for specialty generics unit and more... |
| 2020-02-25 00:15 | | Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition and more... |
| 2020-02-24 12:15 | | Top 10 biotech IPOs in 2019 and more... |
| 2020-02-24 00:15 | | Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease and more... |
| 2020-02-23 00:15 | | A Big Month Ahead for the FDA and Bristol-Myers Squibb and more... |
| 2020-02-22 00:15 | | Esperion adds more competition to cholesterol drug market with newly approved drug and more... |
| 2020-02-21 12:15 | | Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst and more... |
| 2020-02-21 00:15 | | Everest hires ex-Lilly leader to oversee push for Chinese market and more... |
| 2020-02-20 12:15 | | FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq and more... |
| 2020-02-20 00:15 | | J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit and more... |
| 2020-02-19 12:15 | | For two decades, a new vaccine technology has been slowly approaching prime time. Now, can it stop a pandemic? and more... |
| 2020-02-19 00:15 | | FDA keeps the faith in surrogate endpoints and more... |
| 2020-02-18 12:15 | | Gilead Struggles to Recruit Patients for Coronavirus Drug Trial in China and more... |
| 2020-02-18 00:15 | | Blockbusters in waiting: drug launches to watch in 2020 and more... |
| 2020-02-17 12:15 | | Opdivo delivers superior five-year survival results in renal cell carcinoma and more... |
| 2020-02-16 00:15 | | RWE: Cost and Time Savings Entice Sponsors as Pitfalls Linger and more... |
| 2020-02-15 00:15 | | The 20 most expensive pharmacy drugs in the U.S. in 2020, from fallen blockbusters to new orphan meds and more... |
| 2020-02-14 12:15 | | AstraZeneca cans cancer pipeline efforts and more... |
| 2020-02-14 00:15 | | Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks and more... |
| 2020-02-13 12:15 | | Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date and more... |
| 2020-02-12 12:15 | | Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy and more... |
| 2020-02-12 00:15 | | Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development and more... |
| 2020-02-11 12:15 | | Moderna eyes $500M secondary offering on upbeat coronavirus vaccine update — almost ready for the clinic and more... |
| 2020-02-11 00:15 | | AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch and more... |
| 2020-02-10 12:15 | | Wave Life Sciences hits tumultuous waters as ax comes crashing down on staffers and more... |
| 2020-02-10 00:15 | | AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle and more... |
| 2020-02-08 00:15 | | AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs and more... |
| 2020-02-07 12:15 | | Sales rep tips for oncologist calls: Keep it short, use visuals and bring new info, says consultancy and more... |
| 2020-02-07 00:15 | | Everyone’s a Critic: FDA Under Fire for High Drug Approval Numbers and more... |
| 2020-02-06 12:15 | | GSK cutting 720 jobs in manufacturing, R&D and support functions at massive Belgian vaccine hub and more... |
| 2020-02-06 00:15 | | Biogen wins Tecfidera patent challenge from Mylan, sending shares way up and more... |
| 2020-02-05 12:15 | | Merck to spin off new $6.5 billion firm focused on women’s health, older drugs and more... |
| 2020-02-05 00:15 | | Tirzepatide’s time to shine for Lilly and more... |
| 2020-02-04 12:15 | | Johnson & Johnson takes pharma brand crown as Pfizer's value falters: ranking and more... |
| 2020-02-04 00:15 | | Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals and more... |
| 2020-02-03 12:15 | | Gilead climbs as coronavirus drug shows efficacy, starts trial and more... |
| 2020-02-03 00:15 | | J&J Plans to Appeal $344M Transvaginal Mesh Verdict and more... |
| 2020-02-02 01:00 | | Aimmune wins approval for peanut immunotherapy, charges 10k+ and more... |
| 2020-02-02 00:15 | | Aimmune wins approval for peanut immunotherapy, charges 10k+ and more... |
| 2020-02-01 00:45 | | Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies and more... |
| 2020-02-01 00:15 | | Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies and more... |
